Notably, although significant dyslipidemia was observed in fld mice [32], human patients with LPIN1 mutations appeared to have a normal lipid spectrum and did not exhibit insulin resistance or liver steatosis [36]. This evidence concerns the gene LPIN1 and fatty liver disease.